Fabiana Long
Psychiatric/Mental Health · Brandon, FLNPI 1528784121
Payments from drug & device makers
Across 260 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$701
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$607
- Vanda Pharmaceuticals Inc.$556
- Otsuka America Pharmaceutical, Inc.$543
- Axsome Therapeutics, Inc.$462
- Alkermes, Inc.$433
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,63699%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $701 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $607 |
| Vanda Pharmaceuticals Inc. | 25 | $556 |
| Otsuka America Pharmaceutical, Inc. | 29 | $543 |
| Axsome Therapeutics, Inc. | 13 | $462 |
| Alkermes, Inc. | 16 | $433 |
| Almatica Pharma LLC | 22 | $402 |
| Corium, LLC | 22 | $383 |
| Johnson & Johnson | 10 | $318 |
| Collegium Pharmaceutical, Inc. | 9 | $241 |
| Lundbeck LLC | 10 | $224 |
| Noven Therapeutics, LLC | 9 | $163 |
| Neurocrine Biosciences, Inc. | 6 | $138 |
| Indivior Inc. | 5 | $119 |
| Ironshore Pharmaceuticals Inc. | 5 | $95 |
| Harmony Biosciences LLC | 2 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Validus Pharmaceuticals LLC | 1 | $35 |
| Merck | 2 | $34 |
| Neos Therapeutics, LP | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Livanova USA, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,690 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 36 | $56,333 |
| CaplytaLumateperone Tosylate | 27 | $47,805 |
| Lurasidone Hcl | 36 | $33,665 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $16,219 |
| Loreev XrLorazepam | 15 | $6,546 |
| Jornay PmMethylphenidate Hcl | 12 | $5,948 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 143 | $5,890 |
| Methylphenidate ErMethylphenidate Hcl | 22 | $5,575 |
| Aripiprazole | 28 | $5,231 |
| Quetiapine Fumarate | 68 | $4,246 |
| Clonazepam | 211 | $2,802 |
| Alprazolam | 266 | $2,240 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $2,128 |
| Eszopiclone | 38 | $1,889 |
| Mirtazapine | 65 | $1,380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $701 | $56,33336 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $607 | $47,80527 claims |
| Axsome Therapeutics, Inc.Auvelity | $462 | $16,21911 claims |
| Almatica Pharma LLCLoreev Xr | $402 | $6,54615 claims |
| Ironshore Pharmaceuticals Inc.Jornay Pm | $95 | $5,94812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Brandon
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.